Guggenheim Raises Numbers on CVS Caremark (CVS)

Analysts at Guggenheim boosted the price target and estimates through 2014 for pharmacy retailer CVS Caremark Corporation (CVS) on Thursday after the company increased its own guidance.

The analysts maintain a “Buy” rating on CVS and now see shares reaching $60. This new target suggests a 17% upside to Wednesday’s closing price of $51.24.

CVS shares were down slightly during morning trading on Thursday. The stock is up about +19% over the past year.

The Bottom Line
Shares of CVS Caremark (CVS) have a dividend yield of 1.76% based on Thursday’s intraday trading price of $51.12 and the company’s annualized dividend payout of 90 cents per share.

CVS Caremark Corporation (CVS) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here